Treatment of Heart Failure-Al-Mehdi Flashcards
what must be present for diagnosis of HF
increase in LA pressure (increase in PCWP)
HF mortality rate=
50% w/in 5 years of diagnosis
ischemia-MI
HTN, stenosis
Arrythmias
cause HFrEF
LV hypertrophy
HTN
myocardial fibrosis
cause HFpEF
binds ______ in hypothalamus that then makes POMC (and alpha-MSH)
leptin; arcuate nucleus
alpha-MSH binds ____ receptor on PVN neurons that inhibit______ causing RVLM stimulation and sympathetic activation
MC4 receptors; NTS receptors
what leads to LV workload increasing and maladaptive remodeling and hypertrophy of LV
renin increasing Ang II leading to vasoconstriction and increase in afterload
myocyte hypertrophy/necrosis and perivascular and interstitial fibrosis
concentric remodeling
this leads to ventricular enlargement and systolic/diastolic dysfunction and changes in wall stress
concentric remodeling
1st hit after concentric remodeling where you can still preserve EF
concentric LVH
2nd hit to the heart from MI/myocarditis can lead to what
eccentric LVH dilatation
force holding aortic valve closed
diastolic pressure
what is the same in HFpEF and HFrEF
LVEDP
pathognomonic sign of HF
orthopnea
most common sign of HF
Dyspnea
what causes dyspnea in HF
interstitial pulmonary edema
another sign of HF in lower extremities
pitting edema
what causes increase in PCWP in HF
congestion (pulmonary edema)
muscle mass loss
cachexia
what causes cachexia and can lead to anorexia
TNFalpha increase in CHF
what cytokines also increase in CHF
IL-6 and CRP
lab that is highly pathognomonic of cardiovascular disease
NT-proBNP
biomarker in CVD for myocyte necrosis
Troponin Ic
biomarker in CVD for inflammation
CRP, IL-6
biomarker in CVD for accelerated atherosclerosis
LDL
HbA1c
BG
biomarker in CVD for vascular damage
CrCl, Cystatin C, microalbuminuria
biomarker in CVD for hemodynamic stress
NT-proBNP
normal EF
around 67% (2/3rds of contents ejected out)
first line Rx for HFrEF
ARBs/ACEIs
beta blockers
ARNI
Aldosterone antagonists
specific beta blockers used to treat HFrEF (nbmc)
carvedilol
bisoprolol
nebivolol
metoprolol
ARNI made up of what 2 drugs
Valsartan + Sacubitril
Ang II receptor that is involved with maladaptive remodeling
AT1R (Gq)
what two drugs decrease mortality in patients with HFrEF
ACEIs/ARBs and beta blockers
mechanistic reasoning why you use beta blockers in HFrEF
reduce preload and increase beta receptor density
what drugs should not be used in HFrEF
cardiac CCB’s
SGLT2i
-GLIFLOZIN
sGC agonists (like NO)
-CIGUAT
second line for HFrEF
SGLT2i
sGC agonists
Ivabradine
omecamtiv mecarbil
myosin activator used to treat HFrEF
Omecamtiv mecarbil
act at PCT S1 location and inhibit Na+-glucose cotranporter
SGLT2i (-GLIFLOZINs)
3rd line treatment of HFrEF and its SE’s
Digoxin; yellow eyes and anorexia
used to treat AFIB/arrhythmia in HFrEF
AMIODARONE
HFrEF stage with structural heart disease and treated w/ ARBs/ACEIs
stage B or II
stage of HFrEF when symptoms start
stage C or III
rate limiting step of inotropy by myosin activation/inactivation
ADP-Pi dissociation
prevents premature ADP-Pi dissociation and activates myosin directly
Omecamtiv Mecarbil
myosin inactivator
MAVACAMTEN
max reduction in mortality w/ HFrEF
OMECAMTIV MECARBIL
microvascular endothelial inflammation by comorbidities (decrease in NO)
pathogenesis of HFpEF
Rx of HFpEF
ACEIs/ARBs
ARNI
SGLT2i
antifibrotic agents
vasodilator peptide drugs used to treat HFpEF
ANP, CNP, urodilantin
_____ elevation is pathognomonic for HFpEF
NT-proBNP
ANP and BNP cause what when PKG is activated
natriuresis
human ANP (hANP)
CARPERITIDE
human BNP (hBNP)
NESERITIDE
sign of CHF when you have sob while laying down and it is relieved by standing up
orthopnea
causes of acute heart failure
MI/ischemia
iatrogenic volume overload
symptoms of______ in acute HF include: dyspnea, lower extremity swelling, abdominal discomfort
congestion
symptoms of _____ in acute HF include: fatigue, dizziness, and confusion
low perfusion
to treat AHF w/ hypoperfusion
dobutamine, dopamine, milrinone
to treat AHF w/out volume overload
NTG
sodium nitroprusside
nesiritide
to treat AHF w/ normotensive and w/ volume overload
loop diuretics
to treat AHF w/ pulmonary edema
vasodilators
diuretics
first line treatment for AHF
NO donor vasodilators (NTG, sodium nitroprusside)
loop diuretics (furosemide, torsemide)